Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
7-10 Yr Trsy Bear 3X Direxion | TYO | Sep 20, 2024 | 12.49 | +0.08 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Sep 20, 2024 | 28.74 | -0.14 |
7-10 Yr Trsy Ishares | IEF | Sep 20, 2024 | 98.42 | -0.03 |
89bio | ETNB | Sep 20, 2024 | 8.19 | -1.21 |
8x8 | EGHT | Sep 20, 2024 | 1.89 | 0.00 |
908 Devices | MASS | Sep 20, 2024 | 3.68 | -4.17 |
99 Acquisition Group | NNAGU | Sep 20, 2024 | 10.60 | 0.00 |
99 Acquisition Group | NNAG | Sep 20, 2024 | 10.55 | 0.00 |
9F ADR | JFU | Sep 20, 2024 | 1.26 | -19.23 |
A SPAC I Acquisition Unit | ASCAU | Sep 20, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | Sep 20, 2024 | 11.19 | 0.00 |
A-Mark Precious Metals | AMRK | Sep 20, 2024 | 43.05 | -0.88 |
a.k.a Brands | AKA | Sep 20, 2024 | 24.96 | -0.16 |
A.O Smith | AOS | Sep 20, 2024 | 82.89 | -1.66 |
A10 Networks | ATEN | Sep 20, 2024 | 14.02 | +0.29 |
A2Z Smart Technologies | AZ | Sep 20, 2024 | 0.78 | +11.53 |
AAA - A Rated Corporate Bond Ishares | QLTA | Sep 20, 2024 | 49.30 | +0.06 |
Aadi Bioscience | AADI | Sep 20, 2024 | 1.93 | +5.46 |
AAON | AAON | Sep 20, 2024 | 104.05 | +1.56 |
AAR | AIR | Sep 20, 2024 | 69.28 | -0.39 |
Abacus Life | ABL | Sep 20, 2024 | 10.22 | +3.34 |
Abbott Laboratories | ABT | Sep 20, 2024 | 113.70 | -0.39 |
AbbVie | ABBV | Sep 20, 2024 | 193.47 | -0.08 |
AbCellera Biologics | ABCL | Sep 20, 2024 | 2.59 | -5.47 |
Abeona Therapeutics | ABEO | Sep 20, 2024 | 6.02 | +3.79 |
Abercrombie & Fitch | ANF | Sep 20, 2024 | 141.80 | +1.78 |
Aberdeen Asia-Pacificome Fund | FAX | Sep 20, 2024 | 17.51 | +0.29 |
Aberdeen Australia Equity Fund | IAF | Sep 20, 2024 | 4.60 | -1.71 |
Aberdeen Emerging Markets Fund | AEF | Sep 20, 2024 | 5.45 | -0.11 |
Aberdeen Global Fund | FCO | Sep 20, 2024 | 6.02 | +1.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.